Drug intelligence / Profile preview

metoprolol succinate + felodipine

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral
01

Overview

Metoprolol succinate + felodipine is a fixed-dose oral combination of two antihypertensive agents used to treat high blood pressure. Metoprolol succinate is a beta1-selective adrenergic receptor blocker (beta-blocker) that reduces heart rate and cardiac output by antagonizing beta1-adrenoceptors in the heart, leading to decreased blood pressure and reduced myocardial oxygen demand[5][8]. Felodipine is a long-acting dihydropyridine calcium channel blocker that inhibits L-type calcium channels in vascular smooth muscle, resulting in vasodilation and decreased peripheral resistance[6]. The combination provides additive antihypertensive effects by targeting both cardiac output and vascular tone, offering improved blood pressure control compared to either agent alone without compromising tolerability[1][3].

Brand names
Logimax
Other names
felodipine/metoprololfelodipine and metoprololfelodipine-metoprolol combination tablet
02

Targets

ADRB1 (β1)LTCC (Voltage-gated calcium channel (L-type))

Beyond the preview

Go deeper on metoprolol succinate + felodipine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metoprolol succinate + felodipine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call